Starrett will succeed Co-Founder/CEO Nat Turner who, together with Co-Founder/COO Zach Weinberg, will step down from Flatiron administration on April 16.
“I am honored and energized by the opportunity to lead Flatiron in our next chapter,” mentioned Starrett, who joined Flatiron in 2016. “I love Flatiron – our mission, our people, our culture. I’m excited to lead us to even greater impact on patient care and innovation in the field of real-world data, and to build a workforce that reflects the diversity of the many people who live with cancer.”
Founded in 2012, Flatiron has constructed the main U.S. oncology real-world information supply, from which its specialists combination, de-identify, and curate medical, genomic, and different information modalities for analysis functions. More than 280 group most cancers clinics throughout the United States middle their practices on Flatiron’s OncoCloud™ platform and providers, and Flatiron additionally companions with main tutorial most cancers facilities, greater than 20 prime builders of oncology therapeutics, and researchers and regulators throughout the United States and internationally.
“It has been a privilege to help nurture the pioneering start-up born from Nat and Zach’s vision into the global leader in real-world evidence that Flatiron is today,” mentioned Severin Schwan, CEO of Roche Group, which acquired Flatiron as an impartial affiliate in 2018. “Carolyn’s passion for Flatiron, her experience in technology and healthcare, and her ability to rally people around a shared vision are the perfect mix to lead Flatiron’s next life stage. I look forward to continued partnership and support.”
“We conducted an extensive search and could not have been happier to realize that the right candidate was already here at home,” mentioned Turner, who will stay Chair of Flatiron’s Board of Directors. “It’s time for a new leader to take Flatiron to the next level, and I have every confidence in handing over the reins to Carolyn.”
Flatiron Health is a healthtech firm devoted to serving to most cancers facilities thrive and ship higher take care of sufferers at present and tomorrow. Through medical and information science, we translate affected person experiences into real-world proof to enhance remedy, inform coverage, and advance analysis. Together, we are able to outsmart most cancers. Flatiron Health is an impartial affiliate of the Roche Group. Flatiron.com @FlatironHealth